ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/TBUO-C20-GAMMA-GLU(AEEA)-OTBU
C39H72N2O10
729 g/mol
Pharmaceutical Intermediate

TBUO-C20-GAMMA-GLU(AEEA)-OTBU

CAS2645421-68-5
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

This compound is a lipidated peptide building block used in pharmaceutical research. It features a tert-butyl-protected eicosanoic acid chain linked to a gamma-glutamate moiety with a hydrophilic AEEA spacer, and tert-butyl ester protection.

lipidated peptide synthesispharmaceutical intermediateresearch reagent for peptide engineering

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing TBUO-C20-GAMMA-GLU(AEEA)-OTBU?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongStructure SimilarSimilarity 0.96

TBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu

CAS1118767-16-0

pharmaceutical intermediate

StrongStructure SimilarSimilarity 0.96

(S)-22-(tert-Butoxycarbonyl)-45,45-dimethyl-10,19,24,43-tetraoxo-3,6,12,15,44-pentaoxa-9,18,23-triazahexatetracontanoic acid

CAS1188328-37-1

pharmaceutical intermediate

ReferenceSame Category

2,5-Difluorobenzaldehyde

CAS2646-90-4

pharmaceutical intermediate

ReferenceSame Category

2,3-Difluorobenzaldehyde

CAS2646-91-5

pharmaceutical intermediate

ReferenceSame Category

1-Boc-4-Ethylaminopiperidine

CAS264905-39-7

pharmaceutical intermediate

ReferenceSame Category

4-[[[(2S,3R,4R,5S)-3-(3,4-Difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-2-furanyl]carbonyl]amino]-2-pyridinecarboxamide

CAS2649467-57-0

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

2-[2-[2-[[(4S)-5-[(2-methylpropan-2-yl)oxy]-4-[[20-[(2-methylpropan-2-yl)oxy]-20-oxoicosanoyl]amino]-5-oxopentanoyl]amino]ethoxy]ethoxy]acetic acid

InChIKey

MSLFQZZJWZDCCZ-YTTGMZPUSA-N

SMILES

CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)O)C(=O)OC(C)(C)C

Synonyms (7)
  • C20-OtBu-Glu(AEEA-OH)-OtBu
  • C20-OtBu-Glu(OtBu)-AEEA-OH
  • Semaglutide Impurity 146
  • TBUO-C20-GAMMA-GLU(AEEA)-OTBU
  • tBuO-C20-?-Glu(AEEA)-OtBu

Sourcing TBUO-C20-GAMMA-GLU(AEEA)-OTBU?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→